BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C, Barp N, Gallerani A, Tognon M, Contini C. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 2021;13:1687. [PMID: 34578269 DOI: 10.3390/v13091687] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
Number Citing Articles
1 Nicot F, Trémeaux P, Latour J, Carcenac R, Demmou S, Jeanne N, Ranger N, De Smet C, Raymond S, Dimeglio C, Izopet J. Whole-genome single molecule real-time sequencing of SARS-CoV-2 Omicron. J Med Virol 2023;95:e28564. [PMID: 36756931 DOI: 10.1002/jmv.28564] [Reference Citation Analysis]
2 Emire MS, Shiferaw BZ. Attitudes towards receiving COVID-19 vaccine and its associated factors among Southwest Ethiopian adults, 2021. PLoS One 2023;18:e0280633. [PMID: 36689539 DOI: 10.1371/journal.pone.0280633] [Reference Citation Analysis]
3 Ul Haq I, Krukiewicz K, Yahya G, Haq MU, Maryam S, Mosbah RA, Saber S, Alrouji M. The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine. Int J Mol Sci 2023;24. [PMID: 36675046 DOI: 10.3390/ijms24021536] [Reference Citation Analysis]
4 Skrzat-Klapaczyńska A, Kowalska JD, Paciorek M, Puła J, Bieńkowski C, Krogulec D, Stengiel J, Pawełczyk A, Perlejewski K, Osuch S, Radkowski M, Horban A. Higher Immunological Response after BNT162b2 Vaccination among COVID-19 Convalescents-The Data from the Study among Healthcare Workers in an Infectious Diseases Center. Vaccines (Basel) 2022;10. [PMID: 36560567 DOI: 10.3390/vaccines10122158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fleury H. HIV and SARS-CoV-2 Pathogenesis and Vaccine Development. Viruses 2022;14. [PMID: 36560600 DOI: 10.3390/v14122598] [Reference Citation Analysis]
6 Tao Y, Ma M, Hu F, Li M, Geng Y, Wan Y, Mao M, Chen L, Shen Y, Zhu L, Shen H, Chen Y. A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort. BMC Immunol 2022;23:57. [DOI: 10.1186/s12865-022-00532-1] [Reference Citation Analysis]
7 Guarino M, Perna B, Maritati M, Remelli F, Trevisan C, Spampinato MD, Costanzini A, Volpato S, Contini C, De Giorgio R. Presepsin levels and COVID-19 severity: a systematic review and meta-analysis. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00936-8] [Reference Citation Analysis]
8 Rahman S, Hossain MJ, Nahar Z, Shahriar M, Bhuiyan MA, Islam MR. Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic. Environ Health Insights 2022;16:11786302221129396. [PMID: 36299441 DOI: 10.1177/11786302221129396] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Streibl BI, Lahne H, Grahl A, Agsten P, Bichler M, Büchl C, Damzog M, Eberle U, Gärtner S, Hobmaier B, Margos G, Hoch M, Jungnick S, Jonas W, Katz K, Laubert L, Schutt B, Seidl C, Treis B, Weindl D, Zilch K, Wildner M, Liebl B, Ackermann N, Sing A, Fingerle V. Epidemiological and Serological Analysis of a SARS-CoV-2 Outbreak in a Nursing Home: Impact of SARS-CoV-2 Vaccination and Enhanced Neutralizing Immunity Following Breakthrough Infection. Microorganisms 2022;10. [PMID: 36144413 DOI: 10.3390/microorganisms10091809] [Reference Citation Analysis]
10 Biagio P, Rosa C, Nicola SM, Fabrizio S, Amerigo P, Giulia Z, Riccardo S, Riccardo V, Paolo R, Lorenzo S, Ivan G, Federico Ii Covid Team. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients. Viruses 2022;14:1951. [PMID: 36146758 DOI: 10.3390/v14091951] [Reference Citation Analysis]
11 Aqeel I, Majid A, Ismail M, Bashir H. Drug Repurposing For SARS-COV-2 Using Molecular Docking. 2022 19th International Bhurban Conference on Applied Sciences and Technology (IBCAST) 2022. [DOI: 10.1109/ibcast54850.2022.9990466] [Reference Citation Analysis]
12 Laguardia GCA, Püschel VAA, Oliveira PP, Faria LR, Cavalcante RB, Coelho ADCO, Santos KBD, Carbogim FDC. Control of airborne particles in surgical procedures during the Covid-19 pandemic: scoping review. Rev Esc Enferm USP 2022;56:e20210579. [PMID: 35899926 DOI: 10.1590/1980-220X-REEUSP-2021-0579en] [Reference Citation Analysis]
13 Khan A, Khan SA, Zia K, Altowyan MS, Barakat A, Ul-Haq Z. Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor. Front Chem 2022;10:892093. [PMID: 35755247 DOI: 10.3389/fchem.2022.892093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Rotondo JC, Martini F, Maritati M, Caselli E, Gallenga CE, Guarino M, De Giorgio R, Mazziotta C, Tramarin ML, Badiale G, Tognon M, Contini C. Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection. Microorganisms 2022;10:1193. [PMID: 35744711 DOI: 10.3390/microorganisms10061193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
15 Bhosle SM, Tran JP, Yu S, Geiger J, Jackson JD, Crozier I, Crane A, Wada J, Warren TK, Kuhn JH, Worwa G. Duplex One-Step RT-qPCR Assays for Simultaneous Detection of Genomic and Subgenomic RNAs of SARS-CoV-2 Variants. Viruses 2022;14:1066. [DOI: 10.3390/v14051066] [Reference Citation Analysis]
16 Luan N, Li T, Wang Y, Cao H, Yin X, Lin K, Liu C. Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro. Front Immunol 2022;13:882856. [PMID: 35464483 DOI: 10.3389/fimmu.2022.882856] [Reference Citation Analysis]
17 Qaqish A, Abbas MM, Al-Tamimi M, Abbas MA, Al-Omari M, Alqassieh R. SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals. Vaccines (Basel) 2022;10. [PMID: 35632399 DOI: 10.3390/vaccines10050643] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Hasan DA, Maulud SQ, Jalal PJ, Priyanka, Choudhary OP. SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: a case report. Hum Vaccin Immunother 2022;:1-3. [PMID: 35417318 DOI: 10.1080/21645515.2022.2055947] [Reference Citation Analysis]
19 Kogoj R, Korva M, Knap N, Resman Rus K, Pozvek P, Avšič-županc T, Poljak M. Comparative Evaluation of Six SARS-CoV-2 Real-Time RT-PCR Diagnostic Approaches Shows Substantial Genomic Variant–Dependent Intra- and Inter-Test Variability, Poor Interchangeability of Cycle Threshold and Complementary Turn-Around Times. Pathogens 2022;11:462. [DOI: 10.3390/pathogens11040462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Guarino M, Perna B, Remelli F, Cuoghi F, Cesaro AE, Spampinato MD, Maritati M, Contini C, De Giorgio R. A New Early Predictor of Fatal Outcome for COVID-19 in an Italian Emergency Department: The Modified Quick-SOFA. Microorganisms 2022;10. [PMID: 35456856 DOI: 10.3390/microorganisms10040806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Sutharattanapong N, Thotsiri S, Kantachuvesiri S, Wiwattanathum P. Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients. Vaccines 2022;10:572. [DOI: 10.3390/vaccines10040572] [Reference Citation Analysis]
22 Ahmed SF, Sohail MS, Quadeer AA, Mckay MR. Identification of Potential SARS-CoV-2 CD8+ T Cell Escape Mutants. Vaccines 2022;10:542. [DOI: 10.3390/vaccines10040542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Jaspe RC, Zambrano JL, Hidalgo M, Sulbarán Y, Loureiro CL, Moros ZC, Garzaro DJ, Liprandi F, Rangel HR, Pujol FH. Detection of the Omicron variant of SARS-CoV-2 by restriction analysis targeting the mutations K417N and N440K of the spike protein. Investigación Clínica 2022;63:92-9. [DOI: 10.54817/ic.v63n1a08] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Al-awwal N, Dweik F, Mahdi S, El-dweik M, Anderson SH. A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time. Pathogens 2022;11:368. [DOI: 10.3390/pathogens11030368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
25 Rotondo JC, Mazziotta C, Lanzillotti C, Stefani C, Badiale G, Campione G, Martini F, Tognon M. The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications. Cancers (Basel) 2022;14:1116. [PMID: 35267424 DOI: 10.3390/cancers14051116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
26 Nicolò MS, Rizzo MG, Palermo N, Gugliandolo C, Cuzzocrea S, Guglielmino SPP. Evaluation of Betacoronavirus OC43 and SARS-CoV-2 Elimination by Zefero Air Sanitizer Device in a Novel Laboratory Recirculation System. Pathogens 2022;11:221. [DOI: 10.3390/pathogens11020221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Álvarez-díaz DA, Muñoz AL, Tavera-rodríguez P, Herrera-sepúlveda MT, Ruiz-moreno HA, Laiton-donato K, Franco-muñoz C, Pelaez-carvajal D, Cuellar D, Muñoz-suarez AM, Galindo M, Arias-ramírez EJ, Mercado-reyes M. Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia. Vaccines 2022;10:180. [DOI: 10.3390/vaccines10020180] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
28 Mazziotta C, Pellielo G, Tognon M, Martini F, Rotondo JC. Significantly Low Levels of IgG Antibodies Against Oncogenic Merkel Cell Polyomavirus in Sera From Females Affected by Spontaneous Abortion. Front Microbiol 2021;12:789991. [PMID: 34970247 DOI: 10.3389/fmicb.2021.789991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
29 Laguardia GCDA, Püschel VADA, Oliveira PPD, Faria LRD, Cavalcante RB, Coelho ADCO, Santos KBD, Carbogim FDC. Controle de partículas aéreas nos procedimentos cirúrgicos durante a pandemia da Covid-19: revisão de escopo. Rev esc enferm USP 2022;56:e20210579. [DOI: 10.1590/1980-220x-reeusp-2021-0579pt] [Reference Citation Analysis]
30 Alshehri A, Hakami A. Seropositivity of COVID-19 asymptomatic nurses using Anti-SARS-CoV-2 nucleocapsid antibodies. King Khalid Univ J Health Sci 2022;7:91. [DOI: 10.4103/kkujhs.kkujhs_28_22] [Reference Citation Analysis]
31 Hamill V, Noll L, Lu N, Tsui WNT, Porter EP, Gray M, Sebhatu T, Goerl K, Brown S, Palinski R, Thomason S, Almes K, Retallick J, Bai J. Molecular detection of SARS-CoV-2 strains and differentiation of Delta variant strains. Transbound Emerg Dis 2021. [PMID: 34964565 DOI: 10.1111/tbed.14443] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
32 Lhomme S, Latour J, Jeanne N, Trémeaux P, Ranger N, Migueres M, Salin G, Donnadieu C, Izopet J. Prediction of SARS-CoV-2 Variant Lineages Using the S1-Encoding Region Sequence Obtained by PacBio Single-Molecule Real-Time Sequencing. Viruses 2021;13:2544. [PMID: 34960813 DOI: 10.3390/v13122544] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
33 Vasudevan S, Baraniuk JN. Understanding COVID-19 Pathogenesis: A Drug-Repurposing Effort to Disrupt Nsp-1 Binding to Export Machinery Receptor Complex. Pathogens 2021;10:1634. [PMID: 34959589 DOI: 10.3390/pathogens10121634] [Reference Citation Analysis]
34 Pedersen ESL, Mallet MC, Lam YT, Bellu S, Cizeau I, Copeland F, Fernandez TL, Manion M, Harris AL, Lucas JS, Santamaria F, Goutaki M, Kuehni CE, Covid-Pcd Patient Advisory Group. COVID-19 Vaccinations: Perceptions and Behaviours in People with Primary Ciliary Dyskinesia. Vaccines (Basel) 2021;9:1496. [PMID: 34960242 DOI: 10.3390/vaccines9121496] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Ferreira CS, Martins YC, Souza RC, Vasconcelos ATR. EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes. PeerJ 2021;9:e12548. [PMID: 34909278 DOI: 10.7717/peerj.12548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Kohmer N, Eckermann L, Böddinghaus B, Götsch U, Berger A, Herrmann E, Kortenbusch M, Tinnemann P, Gottschalk R, Hoehl S, Ciesek S. Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage. J Clin Med 2021;10:5751. [PMID: 34945047 DOI: 10.3390/jcm10245751] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
37 AbuAlhommos AK, Alhadab FE, Almajhad MM, Almutawaa R, Alabdulkareem ST. Community Knowledge of and Attitudes towards COVID-19 Prevention Techniques in Saudi Arabia: A Cross-Sectional Study. Int J Environ Res Public Health 2021;18:12783. [PMID: 34886506 DOI: 10.3390/ijerph182312783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Jaspe RC, Sulbaran Y, Hidalgo M, Hidalgo M, Loureiro CL, Moros ZC, Garzaro DJ, Rangel HR, Pujol FH. A simple method for detection of mutations in amino acid 452 of the Spike protein of SARS-CoV-2 using restriction enzyme analysis. Invest Clin 2021;62:371-7. [DOI: 10.22209/ic.v62n4a07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Lee SH. A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest. Viruses 2021;13:2386. [PMID: 34960655 DOI: 10.3390/v13122386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
40 Lane MA, Walawender M, Webster AS, Brownsword EA, Ingersoll JM, Miller C, Waggoner J, Uyeki TM, Lindsley WG, Kraft CS. Sampling for SARS-CoV-2 Aerosols in Hospital Patient Rooms. Viruses 2021;13:2347. [DOI: 10.3390/v13122347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 De Angelis M, Della-Morte D, Buttinelli G, Di Martino A, Pacifici F, Checconi P, Ambrosio L, Stefanelli P, Palamara AT, Garaci E, Ricordi C, Nencioni L. Protective Role of Combined Polyphenols and Micronutrients against Influenza A Virus and SARS-CoV-2 Infection In Vitro. Biomedicines 2021;9:1721. [PMID: 34829949 DOI: 10.3390/biomedicines9111721] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
42 Tobaiqy M, MacLure K, Elkout H, Stewart D. Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database. Vaccines (Basel) 2021;9:1326. [PMID: 34835256 DOI: 10.3390/vaccines9111326] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
43 Chang V, Goble C, Ramachandran M, Deborah LJ, Behringer R. Editorial on Machine Learning, AI and Big Data Methods and Findings for COVID-19. Inf Syst Front 2021;:1-5. [PMID: 34744495 DOI: 10.1007/s10796-021-10216-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
44 Rotondo JC, Mazziotta C, Lanzillotti C, Tognon M, Martini F. Epigenetic Dysregulations in Merkel Cell Polyomavirus-Driven Merkel Cell Carcinoma. Int J Mol Sci 2021;22:11464. [PMID: 34768895 DOI: 10.3390/ijms222111464] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
45 Umakanthan S, Patil S, Subramaniam N, Sharma R. COVID-19 Vaccine Hesitancy and Resistance in India Explored through a Population-Based Longitudinal Survey. Vaccines (Basel) 2021;9:1064. [PMID: 34696172 DOI: 10.3390/vaccines9101064] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 17.5] [Reference Citation Analysis]